Merck KGaA Looks To Build Cancer ADCs With Caris’s AI Technology

 
• By Joseph Haas
  
Merck KGaA will call on Caris's AI capabilities in cancer ADC development
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business